Storage policies and use of the Danish Newborn Screening Biobank

Journal of Inherited Metabolic Disease

Volumn 30, Issue 4, 2007, Pages 530-536

  Norgaard Pedersen B ^a   Hougaard, D M ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

BLOOD STORAGE; CONFERENCE PAPER; CONGENITAL DISORDER; DENMARK; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENE AMPLIFICATION; GENETIC ANALYSIS; GOVERNMENT REGULATION; HEALTH CARE FACILITY; HUMAN; INFORMED CONSENT; MEDICAL DOCUMENTATION; MEDICAL ETHICS; MEDICAL RESEARCH; NEWBORN SCREENING; PRACTICE GUIDELINE; QUALITY CONTROL; SENSITIVITY ANALYSIS;

BIOETHICS; BIOLOGICAL SPECIMEN BANKS; BLOOD SPECIMEN COLLECTION; COLD; CONFIDENTIALITY; DENMARK; GENETIC TECHNIQUES; HEALTH POLICY; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; QUALITY CONTROL; SPECIMEN HANDLING; TEMPERATURE;

EID: 34548485304     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-007-0631-x     Document Type: Conference Paper

References (42)

1. Aggerbeck H, Nørgaard-Pedersen B, Heron I (1996) Simultaneous quantitation of diphtheria and tetanus antibodies by double antigen, time-resolved fluorescence immunoassay. J Immunol Methods 190: 171-183.
2. Almind G, Nielsen L, Pedersen NS, Riis P (1996) Health science information banks: Biobanks. Copenhagen: Laegeforeningens forlag.
3. Christensen K, Olsen J, Nørgaard-Pedersen B, et al (1999) Oral clefts, transforming growth factor alpha gene variants, and maternal smoking: A population-based case-control study in Denmark, 1991-1994. Am J Epidemiol 149: 248-255.
4. +-ion channel: A novel link between long QT syndrome and sudden infant death syndrome. Am J CARDIOL 95: 433.
5. Danish Ministry of Internal Affairs and Health (2002) An Account on Biobanks. Summary in English, No. 1414, May, 245-248. ISBN 87-601-9562-2.
6. Danish National Committee on Biomedical Research Ethics (2004) Guidelines about notification etc. of a biomedical research project to the committee system on biomedical research ethics, November 2004. Available in English at http://www.cvk.im.dk/ visArtilel.asp?artikelID=1642
7. Eiberg H, Nørgaard-Pedersen B, Nielsen I-M (2003) Cholestasis familiaris Groenlandica/Byler-like disease in Greenland - A population study. Proceedings of the 12th International Congress on Circumpolar Health. Int J Circumpolar Health 63 (Supplement 2): 189-193.
8. Eising S, Svensson J, Skogstrand K, et al (2007) Type 1 diabetes risk analysis on dried blood spot samples from population based newborns. Design and feasibility of an unselected case control study. Endocrinol Metab Clin Immunol [In press].
9. Green NS, Pass KA (2006) Neonatal screening by DNA microarray: Spots and chips. [Opinion.] Nat Rev 6: 147-151.
10. Hansen PS, Nørgaard-Pedersen B, Meinertz H, et al (1994) Incidence of the apolipoprotein B-3500 mutation in Denmark. Clin Chim Acta 230: 101-104.
11. Hartlev M, Lind U (2006) Use of blood samples from the Danish PKU-biobank - a study of the conceptualization of research in law and in action. [In press]. (mette.hartlevψur.ku.dk).
12. Hollegaard MV, Sørensen KM, Petersen HK, Arnardottir MB, Nørgaard-Pedersen B, Thorsen P, Hougaard DM (2007) Whole-genome-amplification and genetic analysis after extraction of proteins from dried blood spots. Clin Chem 53: 1161-1162.
13. Jacobs C, van den Heuvel CM, Stellaard F, Largilliere C, Skovby F, Christensen E (1993) Diagnosis of Zellweger syndrome by analysis of very long-chain fatty acids in stored blood spots collected at neonatal screening. J. Inherit Metab Dis 16: 63-66.
14. Jiang M, Aittomaki K, Nilsson C, et al (1998) The frequency of an inactivating point mutation (566C→T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry. J Clin Endocrinol Metab 83: 4338-4343.
15. Larsen LA, Fosdal I, Andersen PS, et al (1999) Recessive Romano-Ward syndrome associated with compound heterozygosity for two mutations in the KVLQT1 gene. Eur J Hum Genet 7: 724-728.
16. Larsen TB, Lassen JF, Brandslund I, Byriel L, Petersen GB, Nørgaard-Pedersen B (1998) The Arg506Gln mutation (FV Leiden) among a cohort of 4188 unselected Danish newborns. Thromb Res 89: 211-215.
17. Lebech M, Petersen E (1992) Neonatal screening for congenital toxoplasmosis in Denmark: Presentation of the design of a prospective study. Suppl Scand J Infect Dis 84: 75-79.
18. Lebech M, Andersen O, Christensen NC, et al (1999) Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet 353: 1834-1837.
19. Lund AM, Joensen F, Hougaard DM, et al (2007) Carnitine transporter and holocarboxylase synthase deficiencies in the Faroe Islands. J Inherit Metab Dis 30: 341-349.
20. Lundemose JB, Gregersen N, Kølvraa S, et al (1993) The frequency of a disease-causing point-mutation in the gene coding for medium-chain acyl-CoA dehydrogenase (MCAD) in sudden infant death syndrome (SIDS). Acta Paediatr 82: 544-546.
21. Meikle PJ, Ranieri E, Simonsen H et al (2004) Newborn screening for lysosomal storage disorders: Clinical evaluation of a two tier strategy. Pediatrics 114: 909-916.
22. Merryweather-Clarke AT, Simonsen H, Shearman JD, Pointon JJ, Nørgaard-Pedersen B, Robson KJ (1999) A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations. Hum Mutat 13: 154-159.
23. Ministry of Health (1993) Executive order of 14 January 1993. Regulations for the PKU Registry at Statens Serum Institut, Copenhagen: Ministry of Health.
24. Mortensen PB, Nørgaard-Pedersen B, Waltoft BL, et al (2007) Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol Psychiatry 61: 688-693.
25. Naylor EW, Chace DH (1999) Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid, organic acid, and amino acid metabolism. J Child Neurol 14 (Supplement 1): S4-S8.
26. Nilsson C, Jiang M, Pettersson K, et al (1998) Determination of a common genetic variant of luteinizing hormone using DNA hybridization and immunoassays. Clin Endocrinol (Oxf) 49: 369-376.
27. Nørgaard-Pedersen B (1997a) Use of stored samples from the Danish PKU register. In: Knoppers BM, Laberge CM, eds. Human DNA: Law and Policy. The Hague: Kluwer Law International, 303-311.
28. Nørgaard-Pedersen B (1997b) The Danish PKU register and Biobank. In: Proceedings of the Workshop on Human Biobanks: Ethical and Social Issues 9. Nord Biotechnol 59-73.
29. Nørgaard-Pedersen B, Simonsen H (1999) Biological specimen banks in neonatal screening. Acta Paediatr Suppl 88 (432): 106-109.
30. Nørgaard-Pedersen B, Høgdall E, Iitiä A, Arends J, Dahlen P, Vuust J (1999) Immunoreactive trypsin and a comparison of two ΔF508 mutation analyses in newborn screening for cystic fibrosis: an anonymous pilot study in Denmark. Screening 2: 1-11.
31. Oliver S, Stewart R, Hargreaves K, Dezateux C (2005) The storage and use of newborn babies' blood spot cards: A public consultation. London: Social Science Research Unit, Institute of Education, University of London, 23 pages.
32. Olney RS, Moore CA, Ojodu JA, et al (2006) Storage and use of residual dried blood spots from state newborn screening programmes. J. Pediatr 148: 618-622.
33. Olsen J, Melbye M, Olsen SF, et al (2001) The Danish National Birth Cohort - its background, structure and aim. Scand J Public Health 29: 300-307.
34. Paynter RA, Skibola DR, Skibola CF, Buffler PA, Wiemels JL, Smith MT (2006) Accuracy of multiplexed Illumina platform-based single nucleotide polymorphism genotyping compared between genomic and whole genome amplified DNA collected from multiple sources. Cancer Epidemiol Biomarkers Prev 15: 2533-2536.
35. Petersen MB, Brostrøm K, Stibler H, Skovby F (1993) Early manifestations of the carbohydrate-deficient glycoprotein syndrome. J. Pediatr 122: 66-70.
36. Simonsen H, Brandt NJ, Nørgaard-Pedersen B (1998) Neonatal screening in Danmark. Status og fremtidsperspektiver. Ugeskr. Laeg 160: 5777-5782.
37. Skogstrand K, Thorsen P, Nørgaard-Pedersen B, Schendel DE, Sørensen LC, Hougaard DM (2005) Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem 51: 1854-1866.
38. Sørensen KM, Jespersgaard C, Vuust J, Hougaard DM, Nørgaard-Pedersen B, Andersen PS (2007) Whole genome amplification on DNA from filter paper blood spot samples - an evaluation of selected systems. Genet Test 11: 65-71.
39. Therrell BL, Hannon WH, Pass KA, et al (1996) Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: Statement of the Council of Regional Networks for Genetic Services. Biochem Mol Med 57: 116-124.
40. Therrell BL, Johnson A, Williams D (2006) Status of newborn screening programmes in the United States. Pediatrics 117: 5212-5252.
41. Valeur-Jensen AK, Pedersen CB, Westergaard T, et al (1999) Risk factors for parvovirus B19 infection in pregnancy. JAMA 281: 1099-1105.
42. Webster D. (2003) Storage and use of residual dried blood spots. Southeast Asian J Trop Med Public Health 34 (Supplement 3): 49-51.